It is a pharma public limited company based in Hyderabad, Telangana, India, established in 1995.
1995 | Hyderabad, Telangana, India | ActiveAmerican Generics (India) Limited, a active public limited company, was established on 19 April 1995 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239TG1995PLC020046. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹2.68 M.
It upholds a compliant status. Its leadership includes Sunil Srivastava (Director), Venkatasubrahmanyan Ramakrishnan (Managing Director), Bhupendera Prashanth Ramakrishnan (Director). Past directors included Bhupendera Prashanth Ramakrishnan. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat No.301, Sri Rama Mountview Road No.2 Banjarahills, Hyderabad, Hyderabad, Telangana.
U24239TG1995PLC020046
020046
19 April 1995
₹1.00 Cr
₹2.68 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into American Generics (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Srivastava | Director | 19 Apr 1995 | Current |
| Venkatasubrahmanyan Ramakrishnan | Managing Director | 19 Apr 1995 | Current |
| Bhupendera Prashanth Ramakrishnan | Director | 28 May 2018 | Current |
| Lalitha Ramakrishnan | Director | 04 Jul 2001 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 20 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
American Generics (India) Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 6.18% increase. The company also saw a substantial fall in profitability, with a 111.45% decrease in profit. The company's net worth dipped by a decrease of 1.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, American Generics (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with American Generics (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of American Generics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped American Generics (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity American Generics (India) Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
American Generics (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.
Bhupendera Prashanth Ramakrishnan was appointed as a Director was appointed as a Director on 28 May 2018 & has been associated with this company since 7 years 7 months . was recorded as a recent event.
Progress on Lalitha Ramakrishnan was appointed as a Director was appointed as a Director on 04 Jul 2001 & has been associated with this company since 24 years 6 months . was documented.
The activity Sunil Srivastava was appointed as a Director was appointed as a Director on 19 Apr 1995 & has been associated with this company since 30 years 8 months . was completed.
The activity Venkatasubrahmanyan Ramakrishnan was appointed as a Managing Director was appointed as a Managing Director on 19 Apr 1995 & has been associated with this company since 30 years 8 months . was completed.
The CIN of American Generics (India) Limited is U24239TG1995PLC020046.
American Generics (India) Limited is headquartered at Flat No.301, Sri Rama Mountview Road No.2 Banjarahills, Hyderabad, Hyderabad, Telangana.
American Generics (India) Limited was incorporated on 19 April 1995.
The current directors of American Generics (India) Limited are
The primary industry of American Generics (India) Limited is Pharma.
American Generics (India) Limited is unlisted.
The authorized capital of American Generics (India) Limited is ₹1.00 Cr, and the paid-up capital is ₹2.68 M.
The compliance status of American Generics (India) Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX